295 related articles for article (PubMed ID: 30841477)
1. Lysine crotonylation is involved in hepatocellular carcinoma progression.
Wan J; Liu H; Ming L
Biomed Pharmacother; 2019 Mar; 111():976-982. PubMed ID: 30841477
[TBL] [Abstract][Full Text] [Related]
2. Ultradeep Lysine Crotonylome Reveals the Crotonylation Enhancement on Both Histones and Nonhistone Proteins by SAHA Treatment.
Wu Q; Li W; Wang C; Fan P; Cao L; Wu Z; Wang F
J Proteome Res; 2017 Oct; 16(10):3664-3671. PubMed ID: 28882038
[TBL] [Abstract][Full Text] [Related]
3. Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer.
Zhang D; Tang J; Xu Y; Huang X; Wang Y; Jin X; Wu G; Liu P
Cell Death Dis; 2022 Aug; 13(8):717. PubMed ID: 35977926
[TBL] [Abstract][Full Text] [Related]
4. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription.
Wei W; Liu X; Chen J; Gao S; Lu L; Zhang H; Ding G; Wang Z; Chen Z; Shi T; Li J; Yu J; Wong J
Cell Res; 2017 Jul; 27(7):898-915. PubMed ID: 28497810
[TBL] [Abstract][Full Text] [Related]
5. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases.
Fellows R; Denizot J; Stellato C; Cuomo A; Jain P; Stoyanova E; Balázsi S; Hajnády Z; Liebert A; Kazakevych J; Blackburn H; Corrêa RO; Fachi JL; Sato FT; Ribeiro WR; Ferreira CM; Perée H; Spagnuolo M; Mattiuz R; Matolcsi C; Guedes J; Clark J; Veldhoen M; Bonaldi T; Vinolo MAR; Varga-Weisz P
Nat Commun; 2018 Jan; 9(1):105. PubMed ID: 29317660
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
7. Histone lysine crotonylation during acute kidney injury in mice.
Ruiz-Andres O; Sanchez-Niño MD; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB
Dis Model Mech; 2016 Jun; 9(6):633-45. PubMed ID: 27125278
[TBL] [Abstract][Full Text] [Related]
8. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.
Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP
Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208
[TBL] [Abstract][Full Text] [Related]
9. HDAC5 promotes cell proliferation in human hepatocellular carcinoma by up-regulating Six1 expression.
Feng GW; Dong LD; Shang WJ; Pang XL; Li JF; Liu L; Wang Y
Eur Rev Med Pharmacol Sci; 2014; 18(6):811-6. PubMed ID: 24706304
[TBL] [Abstract][Full Text] [Related]
10. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.
Zhao J; Gray SG; Greene CM; Lawless MW
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):247-256. PubMed ID: 30791763
[TBL] [Abstract][Full Text] [Related]
11. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
12. Global Analysis of Lysine 2-Hydroxyisobutyrylome upon SAHA Treatment and Its Relationship with Acetylation and Crotonylation.
Wu Q; Ke L; Wang C; Fan P; Wu Z; Xu X
J Proteome Res; 2018 Sep; 17(9):3176-3183. PubMed ID: 30109935
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
18. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
Huang W; Li J; Guo X; Zhao Y; Yuan X
Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
[TBL] [Abstract][Full Text] [Related]
19. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
